Collectively, the present study demonstrates that RDX improves glucose metabolism by inhibiting inappropriately augmented renal Sglt2 expression, and results in a subsequent glycosuria during the development of type 2 diabetes. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.